Mabion S.A. (WSE:MAB)
Poland flag Poland · Delayed Price · Currency is PLN
7.37
+0.04 (0.55%)
Jul 24, 2026, 5:00 PM CET

Mabion Revenue

Mabion had revenue of 4.57M PLN in the quarter ending March 31, 2026, with 68.30% growth. This brings the company's revenue in the last twelve months to 17.61M, down -53.36% year-over-year. In the year 2025, Mabion had annual revenue of 15.76M, down -77.17%.

Revenue (ttm)
17.61M
Revenue Growth
-53.36%
P/S Ratio
6.76
Revenue / Employee
87.19K
Employees
204
Market Cap
119.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.76M-53.26M-77.17%
Dec 31, 202469.02M-82.66M-54.50%
Dec 31, 2023151.68M-12.30M-7.50%
Dec 31, 2022163.98M107.11M188.33%
Dec 31, 202156.87M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 20155.47M3.81M229.28%
Dec 31, 20141.66M1.65M13,733.33%
Dec 31, 201312.00K-1.76M-99.32%
Dec 31, 20121.77M-1.97B-99.91%
Dec 31, 20111.97B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BIOTON266.02M
Ryvu Therapeutics88.38M
Synthaverse42.19M
Molecure6.52M
Urteste2.50M
Captor Therapeutics Spolka Akcyjna2.38M
Pharmena1.61M
Poltreg250.00K
Revenue Rankings

Mabion News

More News